Information Journal Paper
APA:
Copy. (2018). A phase 1 study of safety and immunogenicity following intradermal administration of a tetravalent dengue vaccine candidate. VACCINE, 36(27), 3976-3983. SID. https://sid.ir/paper/682552/en
Vancouver:
Copy. A phase 1 study of safety and immunogenicity following intradermal administration of a tetravalent dengue vaccine candidate. VACCINE[Internet]. 2018;36(27):3976-3983. Available from: https://sid.ir/paper/682552/en
IEEE:
Copy, “A phase 1 study of safety and immunogenicity following intradermal administration of a tetravalent dengue vaccine candidate,” VACCINE, vol. 36, no. 27, pp. 3976–3983, 2018, [Online]. Available: https://sid.ir/paper/682552/en